Tracking ctDNA after surgery identifies high-risk patients despite negative MRD status
Skip to content
The CRC Digest
◇ RESEARCH
Tracking ctDNA after surgery identifies high-risk patients despite negative MRD status
A longitudinal study of 124 stage II-III patients found that analyzing circulating tumor DNA (ctDNA) trajectories after surgery can identify subgroups at high risk for recurrence or metastasis, even when initial minimal